Then our futher studies showed that TCDD, a potent AhR agonist, could supresse the growth of gastric cancer cell AGS in a dose- and time-depengent manner via induction of growth arrest at the G1-S phase [9]. This evidence concerns the gene AHR and gastric cancer.